Company research
Fresh2 Group Ltd
CIK 1786511Updated Sep 24, 2026
SecurityFREHY · NASDAQ · adr
Name history
AnPac Bio-Medical Science Co., Ltd. · through May 2, 2023
FREHY price & chart
Loading TradingView…
NASDAQ:FREHY on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 5,867,000Source | 10,592,000Source | 7,645,000Source | 7,611,000Source |
| Property, Plant and Equipment, NetUSD | 2,491,000Source | 3,180,000Source | 2,953,000Source | 2,710,000Source |
| GoodwillUSD | — | 2,002,000Source | 341,000Source | 319,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,439,000Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 271,000Source | 1,452,000Source | 462,000Source | 880,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 324,000Source | 872,000Source | 1,194,000Source | 186,000Source |
| Inventory, NetUSD | 30,000Source | 77,000Source | 48,000Source | 45,000Source |
| Assets, CurrentUSD | 1,986,000Source | 3,696,000Source | 3,262,000Source | 3,185,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,046,000Source | — | — | — |
| Other Assets, NoncurrentUSD | — | — | 71,000Source | 144,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 7,230,000Source | 10,385,000Source | 7,143,000Source | 9,898,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 797,000Source | — | — | — |
| Additional Paid in CapitalUSD | 81,898,000Source | — | — | — |
| Retained Earnings (Accumulated Deficit)USD | -83,735,000Source | -74,639,000Source | -54,705,000Source | -39,712,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 618,000Source | 711,000Source | 735,000Source | 303,000Source |
| Stockholders' Equity Attributable to ParentUSD | -1,982,000Source | -706,000Source | 452,000Source | -2,294,000Source |
| Additional Paid in Capital, Common StockUSD | — | 73,021,000Source | 54,298,000Source | 37,021,000Source |
| Liabilities and EquityUSD | 5,867,000Source | 10,592,000Source | 7,645,000Source | 7,611,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 6,128,000Source | 9,872,000Source | 6,670,000Source | 9,509,000Source |
| Operating Lease, Liability, CurrentUSD | 114,000Source | — | — | — |
| Accounts Payable, CurrentUSD | 303,000Source | — | — | — |
| Operating Lease, Liability, NoncurrentUSD | 945,000Source | — | — | — |
| Deferred Income Tax Liabilities, NetUSD | — | 339,000Source | 160,000Source | 163,000Source |
| Other Liabilities, NoncurrentUSD | 157,000Source | 174,000Source | 313,000Source | 226,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 619,000Source | 913,000Source | 50,000Source | 7,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 360,000Source | — | — | — |
| Short-term InvestmentsCNY | — | 265,826,000Source | — | — |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -15,019,000Source | -18,846,000Source | -12,347,000Source | -14,596,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 682,000Source | 614,000Source | 474,000Source | 383,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,164,000Source | 5,362,000Source | 2,722,000Source | 4,719,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -420,000Source | -242,000Source | 1,112,000Source | -185,000Source |
| Increase (Decrease) in InventoriesUSD | -41,000Source | 28,000Source | 7,000Source | 80,000Source |
| Increase (Decrease) in Accounts PayableUSD | -91,000Source | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | -313,000Source | -185,000Source | -13,000Source | 13,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -7,983,000Source | -11,252,000Source | -9,035,000Source | -6,980,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -231,000Source | -618,000Source | -380,000Source | -497,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 211,000Source | 612,000Source | 378,000Source | 401,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 7,173,000Source | 13,090,000Source | 9,339,000Source | 6,622,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -1,070,000Source | 979,000Source | -477,000Source | -971,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 271,000Source | 1,452,000Source | 462,000Source | 880,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 39,000Source | 343,000Source | 370,000Source | 148,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | 5,362,000Source | 2,722,000Source | 4,719,000Source |
| Amortization of Intangible AssetsUSD | 130,000Source | — | — | — |
| Deferred Other Tax Expense (Benefit)USD | 313,000Source | — | — | — |
| DepreciationUSD | 548,000Source | 428,000Source | 374,000Source | 296,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | 1,098,000Source | -761,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -114,000Source | -32,000Source | -102,000Source | -461,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | -594,000Source |
| General and Administrative ExpenseUSD | 10,263,000Source | 12,660,000Source | 11,457,000Source | 10,167,000Source |
| GoodwillUSD | — | 2,002,000Source | 341,000Source | 319,000Source |
| Goodwill, Impairment LossCNY | 12,758,000Source | 2,223,000Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | 1,147,000Source | 601,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | 23,000Source | 21,000Source | -2,000Source | 27,000Source |
| Income Tax Expense (Benefit)USD | -309,000Source | -185,000Source | -13,000Source | -31,000Source |
| Inventory Write-downUSD | — | — | 6,000Source | 44,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,772,000Source | -18,628,000Source | -12,333,000Source | -14,515,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -247,000Source | -218,000Source | -14,000Source | -81,000Source |
| Other Nonoperating Income (Expense)USD | -9,000Source | 155,000Source | 1,394,000Source | -1,023,000Source |
| Other Operating Income (Expense), NetUSD | — | — | — | 54,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 6,838,000Source |
| Proceeds from Noncontrolling InterestsUSD | 23,000Source | — | 57,000Source | 88,000Source |
| Proceeds from Stock Options ExercisedUSD | 6,000Source | 409,000Source | 1,000Source | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 1,428,000Source | 2,822,000Source | 3,143,000Source | 1,558,000Source |
| Cost of RevenueUSD | — | 899,000Source | 1,169,000Source | 869,000Source |
| Operating Income (Loss)USD | -15,195,000Source | -17,591,000Source | -14,491,000Source | -12,795,000Source |
| Other Nonoperating Income (Expense)USD | -9,000Source | 155,000Source | 1,394,000Source | -1,023,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -15,328,000Source | -19,031,000Source | -12,360,000Source | -14,627,000Source |
| Income Tax Expense (Benefit)USD | -309,000Source | -185,000Source | -13,000Source | -31,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -247,000Source | -218,000Source | -14,000Source | -81,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,772,000Source | -18,628,000Source | -12,333,000Source | -14,515,000Source |
| Earnings Per Share, BasicUSD per share | -0.39Source | -1.37Source | — | — |
| Earnings Per Share, DilutedUSD per share | -0.39Source | -1.37Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 38,242,073Source | 13,605,515Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 38,242,073Source | 13,605,515Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 130,000Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | 4,000Source | — | — | 18,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | 1,098,000Source | -761,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -114,000Source | -32,000Source | -102,000Source | -461,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | -594,000Source |
| General and Administrative ExpenseUSD | 10,263,000Source | 12,660,000Source | 11,457,000Source | 10,167,000Source |
| Goodwill, Impairment LossCNY | 12,758,000Source | 2,223,000Source | 0Source | 0Source |
| Gross ProfitUSD | 1,208,000Source | 1,923,000Source | 1,974,000Source | 689,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | -15,328,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | -5,277,000Source | -4,494,000Source | -6,490,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 23,000Source | 21,000Source | -2,000Source | 27,000Source |
| Interest ExpenseUSD | 34,000Source | 668,000Source | 175,000Source | 375,000Source |
| Other Cost of Operating RevenueUSD | 1,746,000Source | — | — | — |
| Other ExpensesUSD | 565,000Source | — | — | — |
| Other General and Administrative ExpenseUSD | 1,052,000Source | — | — | — |
| Other Operating Income (Expense), NetUSD | — | — | — | 54,000Source |
| Research and Development ExpenseUSD | 1,381,000Source | 2,543,000Source | 1,774,000Source | 1,413,000Source |
| Selling and Marketing ExpenseUSD | 1,762,000Source | 3,361,000Source | 3,015,000Source | 1,958,000Source |